Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Pulmonary Hypertension

  Free Subscription


1 Am J Perinatol
1 Am J Physiol Heart Circ Physiol
1 Am J Physiol Lung Cell Mol Physiol
2 Am J Respir Crit Care Med
1 Ann Am Thorac Soc
1 Arterioscler Thromb Vasc Biol
1 Arthritis Res Ther
1 Biochem Biophys Res Commun
1 Br J Pharmacol
1 Cardiovasc Hematol Agents Med Chem
1 Cardiovasc Pathol
1 Cardiovasc Res
1 Children (Basel)
2 Circulation
1 Clin Chest Med
1 Clin Exp Rheumatol
1 Echocardiography
1 Emergencias
2 Eur Heart J
1 Eur Heart J Open
2 Eur J Heart Fail
2 Eur Respir J
1 Heliyon
1 Inn Med (Heidelb)
2 Int J Cardiovasc Imaging
1 Int J Chron Obstruct Pulmon Dis
1 Int J Mol Sci
1 Ir Med J
1 J Am Heart Assoc
1 J Bras Pneumol
1 J Cardiovasc Med (Hagerstown)
2 J Clin Med
1 J Pediatr
1 J Pers Med
1 J Transl Med
1 J Vet Emerg Crit Care (San Antonio)
1 Medicina (Kaunas)
1 Narra J
1 Pediatr Neonatol
1 Pediatr Pulmonol
1 PLoS One
1 Pol Arch Intern Med
1 Pulm Circ
1 Respir Care
2 Respir Res
1 Rev Esp Cardiol (Engl Ed)
1 Rev Med Chil
1 Sci Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Perinatol

  1. GOWDA SH, Patel N
    "Heart of the Matter": Cardiac Dysfunction in Congenital Diaphragmatic Hernia.
    Am J Perinatol. 2023 Apr 3. doi: 10.1055/a-2067-7925.
    PubMed         Abstract available

    Am J Physiol Heart Circ Physiol

  2. FUKUMITSU M, Kawada T, Nishikawa T, Yokota S, et al
    Effects of nitric oxide inhalation on pulmonary arterial impedance: Differences between normal and pulmonary hypertension male rats.
    Am J Physiol Heart Circ Physiol. 2024 May 31. doi: 10.1152/ajpheart.00108.2024.
    PubMed         Abstract available

    Am J Physiol Lung Cell Mol Physiol

  3. SUN XQ, Klouda T, Barnasconi S, Schalij I, et al
    Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
    Am J Physiol Lung Cell Mol Physiol. 2024 May 29. doi: 10.1152/ajplung.00105.2024
    PubMed         Abstract available

    Am J Respir Crit Care Med

  4. SCOTT JV, Moutchia J, McClelland RL, Al-Naamani N, et al
    Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202311-2196.
    PubMed         Abstract available

  5. LEMAY SE, Grobs Y, Romanet C, Martineau S, et al
    Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:1376-1391.
    PubMed         Abstract available

    Ann Am Thorac Soc

  6. MINHAS J, Moutchia J, Al-Naamani N, Mazurek JA, et al
    Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2024;21:858-865.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  7. JHENG JR, DesJardin JT, Chen YY, Huot JR, et al
    Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
    Arterioscler Thromb Vasc Biol. 2024 May 30. doi: 10.1161/ATVBAHA.123.320270.
    PubMed         Abstract available

    Arthritis Res Ther

  8. LI Y, Qian J, Dong X, Zhao J, et al
    The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
    Arthritis Res Ther. 2024;26:109.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  9. CHEN Z, Cui J, Chen Z, Wang J, et al
    Pulmo-protection of long-term swimming exercise via improving insulin sensitivity in monocrotaline-induced pulmonary hypertensive rats.
    Biochem Biophys Res Commun. 2024;723:150159.
    PubMed         Abstract available

    Br J Pharmacol

  10. CSAKI R, Nagaraj C, Almassy J, Khozeimeh MA, et al
    The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension.
    Br J Pharmacol. 2024 May 28. doi: 10.1111/bph.16426.
    PubMed         Abstract available

    Cardiovasc Hematol Agents Med Chem

  11. ALJANABI MA, Alrabadi N, Mahmoud SH, Haddad R, et al
    Sildenafil Effect on Atrial Natriuretic Peptide Level in Pulmonary Hypertensive Rats.
    Cardiovasc Hematol Agents Med Chem. 2024.
    PubMed         Abstract available

    Cardiovasc Pathol

  12. GUTOR SS, Richmond BW, Agrawal V, Brittain EL, et al
    Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome.
    Cardiovasc Pathol. 2024;71:107640.
    PubMed         Abstract available

    Cardiovasc Res

  13. LIU B, Azfar M, Legchenko E, West JA, et al
    ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
    Cardiovasc Res. 2024;120:756-768.
    PubMed         Abstract available

    Children (Basel)

  14. SCHROEDER L, Soltesz L, Leyens J, Strizek B, et al
    Vasoactive Management of Pulmonary Hypertension and Ventricular Dysfunction in Neonates Following Complicated Monochorionic Twin Pregnancies: A Single-Center Experience.
    Children (Basel). 2024;11:548.
    PubMed         Abstract available


  15. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    PubMed         Abstract available

  16. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.

    Clin Chest Med

  17. MOORE J, Altschul E, Remy-Jardin M, Raoof S, et al
    Chronic Thromboembolic Pulmonary Hypertension: Clinical and Imaging Evaluation.
    Clin Chest Med. 2024;45:405-418.
    PubMed         Abstract available

    Clin Exp Rheumatol

  18. BEARZI P, Navarini L, Currado D, Marino A, et al
    Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis.
    Clin Exp Rheumatol. 2024 May 28. doi: 10.55563.
    PubMed         Abstract available


  19. YANG L, Luo D, Huang T, Li X, et al
    New risk model by right ventricle - pulmonary arterial coupling and inferior vena cava from echocardiography in patients with conventional low-intermediate risk pulmonary artery hypertension under targeted treatment.
    Echocardiography. 2024;41:e15850.
    PubMed         Abstract available


  20. TORRES ARRESE M, Barbera Rausell P, Lago Gancedo H, Mata Martinez A, et al
    Usefulness of the pulsed wave doppler flow pattern in the common femoral vein to detect high probability of pulmonary hypertension in patients attended in the emergency department.
    Emergencias. 2024;36:234.

    Eur Heart J

  21. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
    Eur Heart J. 2024 Feb 28:ehae049. doi: 10.1093.
    PubMed         Abstract available

  22. PITRE T, Weatherald J, Humbert M
    Treatments for pulmonary arterial hypertension: navigating through a network of choices.
    Eur Heart J. 2024 Mar 5:ehae106. doi: 10.1093.

    Eur Heart J Open

  23. MAEDER MT, Weber L, Pohle S, Chronis J, et al
    Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
    Eur Heart J Open. 2024;4:oeae037.
    PubMed         Abstract available

    Eur J Heart Fail

  24. PLATZ E, Systrom D, Leopold JA
    Pulmonary congestion in patients with pulmonary arterial hypertension? New insights from lung ultrasound.
    Eur J Heart Fail. 2024;26:825-828.

  25. D'ALTO M, Di Maio M, Argiento P, Romeo E, et al
    Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
    Eur J Heart Fail. 2024 Feb 26. doi: 10.1002/ejhf.3172.
    PubMed         Abstract available

    Eur Respir J

  26. NATHAN SD, Argula R, Trivieri MG, Aziz S, et al
    Inhaled Treprostinil in Pulmonary Hypertension Associated with COPD: PERFECT study results.
    Eur Respir J. 2024 May 29:2400172. doi: 10.1183/13993003.00172-2024.
    PubMed         Abstract available

  27. VALDEOLMILLOS E, Foray C, Albenque G, Batteux C, et al
    Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2301649.


  28. KOIKE H, Nishimura T, Morikawa M
    Quantitative evaluation of pulmonary hypertension using 4D flow MRI: A retrospective study.
    Heliyon. 2024;10:e31177.
    PubMed         Abstract available

    Inn Med (Heidelb)

  29. EICHSTAEDT CA, Shaukat M, Grunig E
    [Heritable pulmonary arterial hypertension].
    Inn Med (Heidelb). 2024;65:560-565.
    PubMed         Abstract available

    Int J Cardiovasc Imaging

  30. LIN K, Sarnari R, Gordon DZ, Markl M, et al
    Radiomics features of the cardiac blood pool to indicate hemodynamic changes in pulmonary hypertension (PH) due to heart failure with preserved ejection fraction (PH-HFpEF).
    Int J Cardiovasc Imaging. 2024 May 27. doi: 10.1007/s10554-024-03131.
    PubMed         Abstract available

  31. NISHII T, Horinouchi H, Namboku T, Sofue K, et al
    Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension.
    Int J Cardiovasc Imaging. 2024 May 26. doi: 10.1007/s10554-024-03119.
    PubMed         Abstract available

    Int J Chron Obstruct Pulmon Dis

  32. BAJWA EK, Cislak D, Kumar A, Li D, et al
    Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    Int J Chron Obstruct Pulmon Dis. 2024;19:1105-1121.
    PubMed         Abstract available

    Int J Mol Sci

  33. AWAD KS, Wang S, Dougherty EJ, Keshavarz A, et al
    BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARgamma Signaling in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2024;25:5403.
    PubMed         Abstract available

    Ir Med J

  34. HIGGINS M, Cullivan S, McCullagh B, Gaine S, et al
    Characteristics of sarcoidosis-associated pulmonary hypertension at the National Pulmonary Hypertension Unit.
    Ir Med J. 2024;117:955.

    J Am Heart Assoc

  35. AGRAWAL A, Bajaj S, Bhagat U, Yesilyaprak A, et al
    Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020.
    J Am Heart Assoc. 2024 May 28:e031632. doi: 10.1161/JAHA.123.031632.
    PubMed         Abstract available

    J Bras Pneumol

  36. FERREIRA EVM, Lucena JS, Oliveira RKF
    The role of the pulmonary function laboratory to assist in disease management: pulmonary hypertension.
    J Bras Pneumol. 2024;50:e20240033.

    J Cardiovasc Med (Hagerstown)

  37. PALAZZUOLI A, Dini FL, Agostoni P, Cartocci A, et al
    Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry).
    J Cardiovasc Med (Hagerstown). 2024;25:457-465.
    PubMed         Abstract available

    J Clin Med

  38. BERTICI RA, Bertici NS, Ridichie A, Fira-Mladinescu O, et al
    Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre.
    J Clin Med. 2024;13:2754.
    PubMed         Abstract available

  39. BALCAN B, Akdeniz B, Peker Y, The Turcosact Collaborators, et al
    Obstructive Sleep Apnea and Pulmonary Hypertension: A Chicken-and-Egg Relationship.
    J Clin Med. 2024;13:2961.
    PubMed         Abstract available

    J Pediatr

  40. HERNANDEZ BS, Shinozaki RM, Grady RM, Drussa A, et al
    Improvement in Echocardiographic and Diagnostic Biomarkers after Systemic Glucocorticoid Therapy in Infants with Pulmonary Hypertension.
    J Pediatr. 2024 May 28:114116. doi: 10.1016/j.jpeds.2024.114116.
    PubMed         Abstract available

    J Pers Med

  41. KADOGLOU NPE, Khattab E, Velidakis N, Gkougkoudi E, et al
    The Role of Echocardiography in the Diagnosis and Prognosis of Pulmonary Hypertension.
    J Pers Med. 2024;14:474.
    PubMed         Abstract available

    J Transl Med

  42. LI X, Ma S, Wang Q, Li Y, et al
    A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension.
    J Transl Med. 2024;22:502.
    PubMed         Abstract available

    J Vet Emerg Crit Care (San Antonio)

  43. GELE RR, Burnotte P, Valcke A, Walker TG, et al
    Retrospective evaluation of a right heart parameter score in the assessment of precapillary pulmonary hypertension in dogs (2017-2021): 135 cases.
    J Vet Emerg Crit Care (San Antonio). 2024 May 29. doi: 10.1111/vec.13394.
    PubMed         Abstract available

    Medicina (Kaunas)

  44. RUDIENE V, Kapleriene L, Laukyte-Sleniene M, Zebrauskiene D, et al
    The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.
    Medicina (Kaunas). 2024;60:750.
    PubMed         Abstract available

    Narra J

  45. SIREGAR FM, Hartopo AB, Haryana SM
    Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.
    Narra J. 2024;4:e579.
    PubMed         Abstract available

    Pediatr Neonatol

  46. KASHAKI M, Mohazzab A, Radgoudarzi M, Bordbar A, et al
    Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial.
    Pediatr Neonatol. 2024 May 22:S1875-9572(24)00077.
    PubMed         Abstract available

    Pediatr Pulmonol

  47. FUKUOKA S, Kaku N, Nagata H, Nagatomo Y, et al
    Extracorporeal membrane oxygenation support for balloon atrial septostomy in a BMPR2 variant-associated pulmonary arterial hypertension.
    Pediatr Pulmonol. 2024;59:1789-1791.

    PLoS One

  48. KRONBERGER C, Willixhofer R, Mousavi RA, Grzeda MT, et al
    The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension.
    PLoS One. 2024;19:e0301483.
    PubMed         Abstract available

    Pol Arch Intern Med

  49. JERMAKOW M, Danielewicz K, Dudzinska K, Bienias P, et al
    Transient severe precapillary pulmonary hypertension caused by eosinophilic granulomatosis with polyangiitis in a patient diagnosed with asthma.
    Pol Arch Intern Med. 2024 May 24:16758. doi: 10.20452/pamw.16758.

    Pulm Circ

  50. HERSI K, Ramani GV, Law JY, Sadek AS, et al
    Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review.
    Pulm Circ. 2024;14:e12362.
    PubMed         Abstract available

    Respir Care

  51. EVANS RA
    The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD.
    Respir Care. 2024;69:697-712.
    PubMed         Abstract available

    Respir Res

  52. YANG Q, Lai B, Xie H, Deng M, et al
    Identification of differentially expressed ER stress-related genes and their association with pulmonary arterial hypertension.
    Respir Res. 2024;25:220.
    PubMed         Abstract available

  53. BA H, Guo Y, Jiang Y, Li Y, et al
    Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics.
    Respir Res. 2024;25:221.
    PubMed         Abstract available

    Rev Esp Cardiol (Engl Ed)

  54. COUTO-MALLON D, Enriquez-Vazquez D, Calvino-Santos R, Velasco-Garcia de Sierra C, et al
    Usefulness of remote pulmonary arterial pressure monitoring in patients with advanced heart failure listed for HT.
    Rev Esp Cardiol (Engl Ed). 2024;77:493-495.

    Rev Med Chil

  55. ACUNA B, Bello-Zepeda J, Montenegro G, Reyes RV, et al
    [Pulmonary hypertension: calcium channel-mediated signaling, present and future pharmacological targets].
    Rev Med Chil. 2023;151:753-763.
    PubMed         Abstract available

    Sci Rep

  56. LIN J, Chen R, Liao H, Zhang Y, et al
    Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
    Sci Rep. 2024;14:12431.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.